צמיחת הכנסות ב-12 חודשים נגררים: NLS Pharmaceutics AG (NLSP)

Can NLS Pharmaceutics AG (NLSP) meet the high demand for narcolepsy treatment? NLS Pharmaceutics AG (NLSP) is integrating ESG principles and bioethics into the development of insomnia treatments, as evidenced by the year-over-year sales trend over the last 12 months on the GURU.Markets chart, where the latest value is recorded as 0.00. This is further supported by the diversification of research and development in the fields of ADHD and cognitive disorders.
פילוחי נתונים אנליטיים מרוכזים עבור NLS Pharma (NLSP)

This indicator captures the percentage change in revenue over the last 12 months relative to the preceding year, allowing for an assessment of the actual cash flow stability. By analyzing the year-over-year commercial revenue dynamics over a rolling year, an investor can determine the effectiveness of the current NLS Pharmaceutics AG (NLSP) strategy to expand its neuro-drug portfolio through potential M&A transactions or the integration of new technological teams.